Trials / Unknown
UnknownNCT03716895
Severe Septic Shock Complications
Identifying Risk Factors for Complications in Severe Septic Shock
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Adults older than 18 years old, admitted to the ICU with a Severe Septic Shock, requiring Norepinephrine at more than 0.25mcg/kg/min, who have signed informed consent form, will be consecutively included, from december 2018 to december 2019. The primary goal is to look for risk factors associated with an increased in lactate clearance Secondary goals are the following: 1. To look for risk factors associated with an increase risk of Hospital and ICU length of stay. 2. To look for risk factors associated with an increase risk of Acute Kidney Injury. 3. To look for risk factors associated with a decrease in days alive and free of Mechanical Ventilation, Vasopressors and Renal Replacement Therapy. 4. To look for risk factors associated with a decrease in Ventilator-free days. 5. To look for risk factors associated with a decrease in Vasopressor-free days. 6. To look for risk factors associated with an increase risk of in-hospital mortality. 7. To look for risk factors associated with an increase risk of Myocardial Infarction and myocardial injury. 8. To look for risk factors associated with an increase risk of Acute Respiratory Distress Syndrome. 9. To compare and validate different risk scores in our cohort.
Conditions
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-12-01
- Completion
- 2020-03-01
- First posted
- 2018-10-23
- Last updated
- 2018-10-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03716895. Inclusion in this directory is not an endorsement.